ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

IMTX Immatics NV

10.77
-0.12 (-1.10%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Immatics NV IMTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.12 -1.10% 10.77 16:16:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.08 10.74 11.18 10.77 10.89
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
21/3/202406:00GLOBEImmatics Announces Full Year 2023 Financial Results and..
22/1/202411:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/1/202407:58EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202419:30GLOBEImmatics Announces Pricing of $175 Million Public Offering
17/1/202415:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202415:01GLOBEImmatics Announces Proposed Public Offering
16/1/202403:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
16/1/202402:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
30/11/202303:00GLOBELevicept Appoints Eliot Forster as CEO
14/11/202306:00GLOBEImmatics Announces Third Quarter 2023 Financial Results and..
08/11/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202306:00GLOBEImmatics Reports Interim Clinical Data from ACTengine®..
24/10/202306:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202306:00GLOBEImmatics Receives FDA Regenerative Medicine Advanced Therapy..
13/9/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
13/9/202316:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/9/202306:00GLOBEModerna and Immatics Announce Strategic Multi-Platform..
11/9/202305:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/8/202315:11EDGAR2Form F-3 - Registration statement by foreign private issuers
17/8/202306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202306:00GLOBEImmatics Announces Second Quarter 2023 Financial Results and..
10/8/202306:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202306:00GLOBEImmatics Initiates Phase 1/2 Clinical Trial to Evaluate..
24/7/202306:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/7/202306:00GLOBEImmatics Announces $35 Million Equity Investment from..
16/5/202306:00GLOBEImmatics Announces First Quarter 2023 Financial Results and..

Su Consulta Reciente

Delayed Upgrade Clock